# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA647432 | F | Inhibitory activity against BT549 cell line; inactive | Homo sapiens | 4 | ALA1128143 | cell-based format | Scientific Literature | |
2. | ALA647433 | F | Tested for cytotoxicity against human breast cancer BT549 cell line | Homo sapiens | 4 | ALA1146596 | cell-based format | Scientific Literature | |
3. | ALA653582 | F | Cytotoxicity against NCI tumor panel, BT-549 breast cancer cell line | Homo sapiens | 1 | ALA1133719 | cell-based format | Scientific Literature | |
4. | ALA653583 | F | Concentration of compound that cause 50% cytotoxicity of BT-549 breast cancer cell line | Homo sapiens | 1 | ALA1145965 | cell-based format | Scientific Literature | |
5. | ALA653584 | F | In vitro cytotoxicity against human breast cancer BT-549 cell line | Homo sapiens | 8 | ALA1130825 | cell-based format | Scientific Literature | |
6. | ALA653585 | F | Cytotoxicity against BT-549 breast cancer cell line | Homo sapiens | 1 | ALA1132166 | cell-based format | Scientific Literature | |
7. | ALA653586 | F | In vitro growth inhibition of compound was determined against BT-549 cell lines of Breast cancer | Homo sapiens | 1 | ALA1133283 | cell-based format | Scientific Literature | |
8. | ALA653587 | F | In vitro growth inhibition of compound was determined against BT-549 cell lines of Breast cancer; NT means Not tested | Homo sapiens | 1 | ALA1133283 | cell-based format | Scientific Literature | |
9. | ALA653588 | F | In vitro growth inhibition of compound was determined against BT-549 cell lines of Breast cancer | Homo sapiens | 3 | ALA1133283 | cell-based format | Scientific Literature | |
10. | ALA653589 | F | Tested for the cytotoxicity against the Breast cancer cell line BT-549, growth inhibition by 50% is reported | Homo sapiens | 5 | ALA1135261 | cell-based format | Scientific Literature | |
11. | ALA653590 | F | Tested for the cytotoxicity against the Breast cancer cell line BT-549, growth inhibition by 50% is reported; not tested | Homo sapiens | 2 | ALA1135261 | cell-based format | Scientific Literature | |
12. | ALA653591 | F | in vitro inhibition of breast (BT-549) cancer cell line | Homo sapiens | 8 | ALA1131509 | cell-based format | Scientific Literature | |
13. | ALA656117 | F | Compound was evaluated for in vitro activity against BT-549 breast cancer cell lines (Human tumor cells ) | Homo sapiens | 3 | ALA1131440 | cell-based format | Scientific Literature | |
14. | ALA656118 | F | Compound was tested for the growth inhibition of BT-549 breast carcinoma cell line | Homo sapiens | 3 | ALA1132605 | cell-based format | Scientific Literature | |
15. | ALA656119 | F | Concentration required for killing 50% of cells of breast BT-549 cell lines was determined in vitro | Homo sapiens | 2 | ALA1134396 | cell-based format | Scientific Literature | |
16. | ALA656120 | F | Compound was tested for growth inhibitory activity against BT-549 cell line | Homo sapiens | 2 | ALA1131541 | cell-based format | Scientific Literature | |
17. | ALA656121 | F | Compound tested for growth inhibition of breast cancer cell line BT-549 | Homo sapiens | 1 | ALA1136555 | cell-based format | Scientific Literature | |
18. | ALA656122 | F | Compound was tested for 50% growth inhibition against human breast cancer BT-549 cell line | Homo sapiens | 1 | ALA1148481 | cell-based format | Scientific Literature | |
19. | ALA876061 | F | Growth inhibition of the BT-549 Breast cancer cell line for 2-day in vitro assay. | Homo sapiens | 2 | ALA1132434 | cell-based format | Scientific Literature | |
20. | ALA656123 | F | In vitro antitumor activity against Breast cancer BT-549 cell lines by 6-day assay | Homo sapiens | 1 | ALA1132564 | cell-based format | Scientific Literature |